Several proteins involved in carcinogenesis or leukemogenesis are increased for clinical responders (ANO6, CHI3L1, CTSG, ELANE and FGR), suggesting that the sensitivity to ATRA/VP additionally depends on more general functions involved in cancer development. Here, ANO6 is linked to cancer.